Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3QQH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,202
Award facts
- Contract value 100% obligated
- $15,202.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) injectable medication, with a contract ceiling value of $15,202.20 and an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive pharmaceutical supply vehicle for federal military and healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order as part of its extensive portfolio of pharmaceutical and medical supply deliveries to the Defense Logistics Agency and supporting agencies including the Defense Health Agency and U.S. Coast Guard. The company's federal contract awards demonstrate consistent capability in delivering brand-name and generic medications across multiple therapeutic domains, including diabetes treatments, neurological medications, pain management pharmaceuticals, and specialized medical supplies. This delivery order for Ozempic, a diabetes medication, exemplifies the company's role in supporting military healthcare program requirements through the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F3QQH?
SPE2DR26F3QQH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F3QQH worth?
The government has obligated $15,202 on SPE2DR26F3QQH.
Is contract SPE2DR26F3QQH an order under another contract?
Yes. SPE2DR26F3QQH is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3QQH competed?
The extent of competition for SPE2DR26F3QQH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award